107 related articles for article (PubMed ID: 28130)
1. [Specific and aspecific activity of an antihistaminic of the H1 type: HC 20-511 or ketothiphen (benzo-cyclohepta-thiophenone derivative)].
Lampa E; Apolito A; Russo G; Pedone P; Alise G
Boll Chim Farm; 1977 Nov; 116(11):644-63. PubMed ID: 28130
[No Abstract] [Full Text] [Related]
2. Some pharmacologic characteristics of a new antihistaminic (SQ 10,648), 11-(2-dimethylaminoethyl)-6,11-dihydrodibenz-[b,e] [1,4] oxazepine maleate.
Rubin B; Piala JJ; Millonig R; Craver BN
Arch Int Pharmacodyn Ther; 1965 May; 155(1):47-56. PubMed ID: 4378646
[No Abstract] [Full Text] [Related]
3. Pharmacological study of antihistaminic principle(s) in the Rana tigrina tissues.
Jayasunder S; Periyasamy SM; Bhide NK
Indian J Physiol Pharmacol; 1973; 17(3):213-25. PubMed ID: 4151007
[No Abstract] [Full Text] [Related]
4. The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.
Martin U; Römer D
Arzneimittelforschung; 1978; 28(5):770-82. PubMed ID: 35171
[No Abstract] [Full Text] [Related]
5. Antihistaminic activity of 4-(2, 1, pyrrolidino-ethoxy) quinoline.
Raina MK; Das PK
Indian J Med Res; 1972 Apr; 60(4):604-19. PubMed ID: 4144983
[No Abstract] [Full Text] [Related]
6. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen).
Dixon AK; Hill RC; Roemer D; Scholtysik G
Arzneimittelforschung; 1977; 27(10):1968-79. PubMed ID: 411500
[No Abstract] [Full Text] [Related]
7. [Pharmacologic and toxicologic studies on benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate--a new spasmolytic].
Osterloh G; Lagler F; Staemmler M; Helm F
Arzneimittelforschung; 1966 Aug; 16(8):901-10. PubMed ID: 6014722
[No Abstract] [Full Text] [Related]
8. [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)].
Engelhardt G
Arzneimittelforschung; 1975 Nov; 25(11):1723-37. PubMed ID: 1049
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
10. [Experimental toxicological and pharmacodynamic studies of a triple drug association (adrenaline, atropine and papaverine) with anti-bronchospastic activity].
Lampa E; Rossi F; Rosatti F; Vacca C; Giordano L; Del Vecchio F; Alise G; Di Tonto B
Arch Sci Med (Torino); 1978; 135(3):327-50. PubMed ID: 708086
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of a new anticholinergic agent, 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504).
Tamaki H; Tanaka M; Murata S; Harigaya S; Kiyomoto A
Jpn J Pharmacol; 1972 Oct; 22(5):685-99. PubMed ID: 4539786
[No Abstract] [Full Text] [Related]
12. [Research on benzofuran series. XLV. Pharmacological properties of exetorone].
Aussems G; Bauthier J; Chaillet F; Colot M; Van Damme M; Charlier R
Therapie; 1971; 26(6):1135-54. PubMed ID: 4401717
[No Abstract] [Full Text] [Related]
13. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
[TBL] [Abstract][Full Text] [Related]
14. [Significance of catecholamines in the anaphylactic reaction].
Bernauer W; Beck E; Mahlstedt J; Resch-Bollhagen S; Hahn F
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):293-4. PubMed ID: 4397498
[No Abstract] [Full Text] [Related]
15. Effect of chlordiazepoxide on bronchoconstriction.
Kovács IB; Görög P
Arch Int Pharmacodyn Ther; 1968 May; 173(1):27-33. PubMed ID: 4385408
[No Abstract] [Full Text] [Related]
16. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK
Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 3-(4-chlorophenyl)-2-(3-substituted propyl thio) quinazolin-4-(3H)-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Parthiban P
Arzneimittelforschung; 2012 Sep; 62(9):433-8. PubMed ID: 22855299
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antilethal, broncholytic, and antiemphysematous activities of mepyramine in anaphylactic, histamine, and anaphylatoxin shock of guinea-pigs.
Bernauer W; Hahn F; Giertz H
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):137-51. PubMed ID: 4390918
[No Abstract] [Full Text] [Related]
20. Ketotifen: a histamine release inhibitor.
Martin U; Roemer D
Monogr Allergy; 1977; 12():145-9. PubMed ID: 72350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
